Standard C&P

Standard C&P (Standard Co., Ltd.) is a leading South Korean in-vitro diagnostics (IVD) company that develops and manufactures a wide range of rapid diagnostic tests and point-of-care testing (POCT) solutions. The company is best known for its "STANDARD" brand, which encompasses various diagnostic modalities including rapid antigen/antibody tests (STANDARD Q), fluorescence immunoassays (STANDARD F), and molecular diagnostics (STANDARD M). Their extensive product portfolio addresses critical global health challenges, providing diagnostic tools for infectious diseases such as COVID-19, malaria, HIV, and tuberculosis, as well as chronic conditions like diabetes and cardiovascular disease. Standard C&P operates as a key player in the global IVD market, focusing on delivering high-quality, accessible, and innovative diagnostic technologies to healthcare systems worldwide.